Search
Amneal Pharmaceuticals Inc
AMRXAdd to Watchlist
19.450USD
-0.500-2.51%
Close 11-05 16:00（ET）
6.77BMarket Cap
50.16P/E TTM
Today
-2.51%
5 Days
-8.90%
1 Month
-4.42%
6 Months
+45.04%
Year to Date
+54.37%
1 Year
+66.38%
Key Figures
20.040Open
20.480High
164.60KVolume
50.16P/E TTM
15.12P/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
19.950Prev. Close
19.385Low
3.24MTurnover
LossP/E Static
-95.69P/B
0.00%Div Yield TTM
5.25%ROA
21.68152wk High
0.03Volume Ratio
-116.89MNet Profit
348.30MShares
0.3877EPS TTM
1.31Beta
-155.38%ROE
11.29552wk Low
7.69%Amplitude
38.73%Gross Margin
6.77BMarket Cap
1.88Reward/Risk
2.21%Risk Rate
Amneal Pharmaceuticals Inc's Score
-0.08vs previous score
Forecast8.86
Financial Health7.93
Technical3.34
Valuation Dimensions8.23
Institutional Confidence5.00
Risk Assessment7.63
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Amneal Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Neutral
Amneal Pharmaceuticals Inc Latest Earnings Call Transcripts
Amneal Pharmaceuticals (AMRX) Q3 2026 Earnings Call: Guidance Raised
Amneal Pharmaceuticals’ Q3 2026 revenue rose 10% to $863 million as adjusted EBITDA grew 30%. AMRX raised its full-year revenue, EBITDA and EPS guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.06/0.23
Revenue / Forecast
862.68M/815.86M
Amneal Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolAMRX
Number of employees8100
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Patel (Tushar Bhikhubhai) | 15.23% |
| Patel (Chintu) | 8.19% |
| Patel (Chirag K) | 7.10% |
| Akram (Mahesh) | 6.44% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 44.13% |
| Investment Advisor | 19.79% |
| Investment Advisor/Hedge Fund | 12.69% |
| Hedge Fund | 11.08% |
Related Instruments
-3.76%
-1.45%
-2.24%
-2.27%
-1.85%
-1.14%
-3.80%
-3.96%
-4.46%
-2.96%
-1.19%
-1.65%
+0.24%
-1.18%
-1.45%
-6.55%
-2.98%
+0.62%
+2.25%
-3.93%Popular Instruments
51065.400
-433.700 (-0.84%)
27037.800
+402.600 (+1.51%)
7381.300
+24.400 (+0.33%)
12797.000
-1.000 (-0.01%)
58283.000
+1017.000 (+1.78%)
6137.300
-40.500 (-0.66%)
90.307
+0.274 (+0.30%)
344.170
-5.340 (-1.53%)
181.600
-18.530 (-9.26%)
4070.220
-28.470 (-0.69%)
FAQs
What is the current price of Amneal Pharmaceuticals Inc (AMRX)?
The current price of Amneal Pharmaceuticals Inc (AMRX) is 19.45.
What is the symbol of Amneal Pharmaceuticals Inc?
The ticker symbol of Amneal Pharmaceuticals Inc is AMRX.
What is the 52-week high of Amneal Pharmaceuticals Inc?
The 52-week high of Amneal Pharmaceuticals Inc is 21.68.
What is the 52-week low of Amneal Pharmaceuticals Inc?
The 52-week low of Amneal Pharmaceuticals Inc is 11.29.
What is the market capitalization of Amneal Pharmaceuticals Inc?
The market capitalization of Amneal Pharmaceuticals Inc is 6.77B.
Is Amneal Pharmaceuticals Inc (AMRX) currently rated as Buy, Hold, or Sell?
According to analysts, Amneal Pharmaceuticals Inc (AMRX) has an overall rating of Buy, with a price target of 23.63.
What is the Earnings Per Share (EPS TTM) of Amneal Pharmaceuticals Inc (AMRX)?
The Earnings Per Share (EPS TTM) of Amneal Pharmaceuticals Inc (AMRX) is 0.39.